Malignant Glioma
Showing 1 - 25 of 124
Glioblastoma, Malignant Glioma Trial in Duarte (Azeliragon, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Glioblastoma
- Malignant Glioma
- Azeliragon
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 6, 2023
Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)
Not yet recruiting
- Diffuse Glioma
- Malignant Glioma
- Biospecimen Collection
- +6 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Feb 6, 2023
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States
Recruiting
- Anaplastic Astrocytoma
- +6 more
- Biopsy
- +3 more
-
Birmingham, Alabama
- +62 more
Feb 2, 2023
Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,
Recruiting
- Malignant Glioma
- High Grade Glioma
- TTRNA-DC vaccines with GM-CSF
- +4 more
-
Birmingham, Alabama
- +2 more
Feb 2, 2023
Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)
Recruiting
- Glioma
- +4 more
- 3T MRI scanner
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)
Recruiting
- Glioblastoma
- +2 more
- TMZ
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))
Active, not recruiting
- Malignant Glioma
- +2 more
- Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
- Concurrent Optune and RT followed by Optune System alone
-
Los Angeles, California
- +8 more
Jan 17, 2023
Malignant Glioma, Recurrent Brain Tumor Trial in Rochester (procedure, drug, other)
Active, not recruiting
- Malignant Glioma
- Recurrent Brain Neoplasm
- Biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic
Jan 5, 2023
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Boston (CARv3-TEAM-E T cells)
Not yet recruiting
- Glioblastoma
- +3 more
- CARv3-TEAM-E T cells
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Dec 13, 2022
Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)
Recruiting
- Malignant Glioma
- Glioblastoma
-
Durham, North CarolinaDuke University Medical Center
Oct 13, 2022
Malignant Glioma Trial in Rochester (Fluorine-18-L-dihydroxyphenylalanine)
Active, not recruiting
- Malignant Glioma
-
Rochester, MinnesotaMayo Clinic
Oct 10, 2022
Malignant Brain Tumor, Malignant Glioma, Embryonal Tumor Trial in Paris, Villejuif (SonoCloud® (9 transducers))
Not yet recruiting
- Malignant Brain Tumor
- +2 more
- SonoCloud® (9 transducers)
-
Paris, France
- +2 more
Sep 26, 2022
Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after
Active, not recruiting
- Oligodendroglioma
- +5 more
- GBM6-AD and poly-ICLC before and after surgery
- GBM6-AD and poly-ICLC after surgery only
-
San Francisco, CaliforniaUniversity of California
Sep 20, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +32 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +124 more
Aug 24, 2022
Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)
Recruiting
- Glioblastoma
- +5 more
- Ipilimumab
- +4 more
-
Birmingham, Alabama
- +19 more
Aug 16, 2022
Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)
Recruiting
- Anaplastic Ependymoma
- +14 more
- Etoposide
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Gliomas Using a Broad Next Generation Sequencing (NGS)Panel
Completed
- Malignant Glioma
- (no location specified)
Aug 2, 2022
Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)
Completed
- Malignant Glioma
- +3 more
- Dendritic Cell Vaccine
- +3 more
-
Miami, FloridaUniversity of Miami
Jul 19, 2022
Malignant Glioma Trial in Rochester (procedure, drug, radiation, other)
Active, not recruiting
- Malignant Glioma
- Diffusion Weighted Imaging
- +6 more
-
Rochester, MinnesotaMayo Clinic
Jul 15, 2022
GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))
Completed
- GBM
- +3 more
- Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
-
Durham, North CarolinaDuke University Medical Center
Jun 28, 2022
Malignant Glioma, Anxiety, Caregiver Burden Trial in Boston (Psychosocial Intervention Group, Usual Care Group)
Active, not recruiting
- Malignant Glioma
- +3 more
- Psychosocial Intervention Group
- Usual Care Group
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jul 12, 2022
Malignant Glioma, Brain Tumor, Recurrent Trial in Durham (D2C7-IT)
Active, not recruiting
- Malignant Glioma
- Brain Tumor, Recurrent
-
Durham, North CarolinaPreston Robert Tisch Brain Tumor Center at Duke
Jul 12, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
-
Birmingham, Alabama
- +113 more
Jun 28, 2022